mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
0.099 |
0.004 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.006 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.006 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.006 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.006 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.007 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.007 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.007 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.008 |